Roel van Kampen

CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells

G. V. D. van der Windt, A. Kater, E. Eldering, 2020, Journal for immunotherapy of cancer.

Regulation of Bcl-XL by non-canonical NF-κB in the context of CD40-induced drug resistance in CLL

A. Kater, S. Mackay, L. Young, 2021, Cell Death & Differentiation.